These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24556477)

  • 1. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
    Houng AK; Wang D; Reed GL
    Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
    Singh S; Houng AK; Reed GL
    Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin.
    Reed GL; Houng AK; Wang D
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2586-93. PubMed ID: 25256235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.
    Reed GL; Houng AK; Singh S; Wang D
    Semin Thromb Hemost; 2017 Mar; 43(2):191-199. PubMed ID: 27472428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
    Saleem S; Wang D; Zhao T; Sullivan RD; Reed GL
    Neuroscience; 2021 Apr; 460():120-129. PubMed ID: 33465414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
    Singh S; Houng AK; Wang D; Reed GL
    J Thromb Haemost; 2016 Sep; 14(9):1822-32. PubMed ID: 27319402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
    Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
    Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
    Kaur J; Tuor UI; Zhao Z; Barber PA
    J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
    Won S; Lee JH; Wali B; Stein DG; Sayeed I
    J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats.
    Tang J; Li YJ; Mu J; Li Q; Yang DY; Xie P
    Neurol Res; 2009 Mar; 31(2):189-94. PubMed ID: 19298760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.
    Fan X; Lo EH; Wang X
    Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.